IOBT

Healthcare

IO Biotech, Inc.

$0.18+0.00 (+2.17%)

Prev Close

$0.17

Open

$0.17

High

$0.19

Low

$0.16

Volume

1.32M

Market Cap

$20.2M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at IO Biotech, Inc. (IOBT) has been exclusively buying, with 1 insider purchase totaling $20.9K and 0 insider sales totaling $0.00. The most recent insider transaction was by Hunter Heidi (Director), who purchased $20.9K worth of shares on May 30, 2025. IO Biotech, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $20.2M.

Buys (12M)

$20.9K

Sells (12M)

$0.00

Net Activity

Net Buyer

$20.9K

Active Insiders

last 12 mo

IOBT Price Chart

IOBT Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 30, 2025↗	Hunter Heidi	Director	Buy	15,000	$1.39	$20.9K	0
Dec 26, 2024↗	Ahmad Qasim Iftikhar	Chief Medical Officer	Buy	31,350	$0.85	$26.6K	31,350
Dec 23, 2024↗	Smith Devin Whittemore	General Counsel	Buy	12,000	$0.81	$9.7K	16,938
Dec 23, 2024↗	Sullivan Amy	Chief Financial Officer	Buy	10,250	$0.83	$8.5K	84,632
Dec 23, 2024↗	Zocca Mai-Britt	Chief Executive Officer	Buy	12,500	$0.81	$10.1K	49,891
Jul 26, 2024↗	Novo Holdings A/S		Sell	75,000	$1.32	$99.1K	4,377,930
May 14, 2024↗	Novo Holdings A/S		Sell	658,809	$1.22	$802.5K	4,429,450
Feb 13, 2024↗	Novo Holdings A/S	10% Owner	Sell	658,809	$1.50	$988.4K	5,088,260
Nov 24, 2023↗	Burkavage Brian	Chief Accounting Officer	Buy	10,000	$1.01	$10.1K	11,500
Aug 11, 2023↗	Novo Holdings A/S	10% Owner	Buy	2,469,135	$2.03	$5.00M	5,707,470
Aug 10, 2023↗	Vivo Capital IX, LLC	10% Owner	Buy	3,157,894	$1.90	$6.00M	3,157,890
Mar 20, 2023↗	Sullivan Amy	Chief Financial Officer	Buy	25,000	$2.32	$58.0K	25,000
Nov 12, 2021↗	Andersson Claus A.		Buy	75,000	$14.00	$1.05M	1,791,490
Nov 12, 2021↗	HBM Healthcare Investments (Cayman) Ltd.	10% Owner	Buy	325,000	$14.00	$4.55M	2,690,540
Nov 12, 2021↗	Lundbeckfond Invest A/S		Buy	2,142,857	$14.00	$30.00M	6,049,450
Nov 12, 2021↗	Malier Vanessa		Buy	162,500	$14.00	$2.27M	958,559
Nov 12, 2021↗	Vivo Capital IX, LLC		Buy	650,000	$14.00	$9.10M	3,015,540
Nov 10, 2021↗	Novo Holdings A/S	10% Owner	Buy	325,000	$14.00	$4.55M	3,277,930

IOBT Insider Buying Activity

The following table shows recent insider purchases of IO Biotech, Inc. (IOBT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 30, 2025↗	Hunter Heidi	Director	Buy	15,000	$1.39	$20.9K	0
Dec 26, 2024↗	Ahmad Qasim Iftikhar	Chief Medical Officer	Buy	31,350	$0.85	$26.6K	31,350
Dec 23, 2024↗	Smith Devin Whittemore	General Counsel	Buy	12,000	$0.81	$9.7K	16,938
Dec 23, 2024↗	Sullivan Amy	Chief Financial Officer	Buy	10,250	$0.83	$8.5K	84,632
Dec 23, 2024↗	Zocca Mai-Britt	Chief Executive Officer	Buy	12,500	$0.81	$10.1K	49,891
Nov 24, 2023↗	Burkavage Brian	Chief Accounting Officer	Buy	10,000	$1.01	$10.1K	11,500
Aug 11, 2023↗	Novo Holdings A/S	10% Owner	Buy	2,469,135	$2.03	$5.00M	5,707,470
Aug 10, 2023↗	Vivo Capital IX, LLC	10% Owner	Buy	3,157,894	$1.90	$6.00M	3,157,890
Mar 20, 2023↗	Sullivan Amy	Chief Financial Officer	Buy	25,000	$2.32	$58.0K	25,000
Nov 12, 2021↗	Andersson Claus A.		Buy	75,000	$14.00	$1.05M	1,791,490
Nov 12, 2021↗	HBM Healthcare Investments (Cayman) Ltd.	10% Owner	Buy	325,000	$14.00	$4.55M	2,690,540
Nov 12, 2021↗	Lundbeckfond Invest A/S		Buy	2,142,857	$14.00	$30.00M	6,049,450
Nov 12, 2021↗	Malier Vanessa		Buy	162,500	$14.00	$2.27M	958,559
Nov 12, 2021↗	Vivo Capital IX, LLC		Buy	650,000	$14.00	$9.10M	3,015,540
Nov 10, 2021↗	Novo Holdings A/S	10% Owner	Buy	325,000	$14.00	$4.55M	3,277,930

IOBT Insider Selling Activity

The following table shows recent insider sales of IO Biotech, Inc. (IOBT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 26, 2024↗	Novo Holdings A/S		Sell	75,000	$1.32	$99.1K	4,377,930
May 14, 2024↗	Novo Holdings A/S		Sell	658,809	$1.22	$802.5K	4,429,450
Feb 13, 2024↗	Novo Holdings A/S	10% Owner	Sell	658,809	$1.50	$988.4K	5,088,260